Literature DB >> 8848207

Oral sumatriptan-associated transmural myocardial infarction.

P O'Connor1, P Gladstone.   

Abstract

A 43-year-old healthy man developed transmural myocardial infarction shortly after ingesting sumatriptan succinate 100 mg for migraine. Coronary arteriography revealed only minor irregularities in the left anterior descending artery. Oral sumatriptan should be used with caution in any patient with vascular risk factors and avoided in those with coronary artery disease or vasospasm.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8848207     DOI： 10.1212/wnl.45.12.2274

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  12 in total

1.  A case of myocardial infarction with sumatriptan use.

Authors:  E Erbilen; H Ozhan; R Akdemir; M Yazici
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 2.  5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?

Authors:  Lars Neeb; Jannis Meents; Uwe Reuter
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

Review 3.  The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine.

Authors:  Uwe Reuter; Heike Israel; Lars Neeb
Journal:  Ther Adv Neurol Disord       Date:  2015-01       Impact factor: 6.570

4.  Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.

Authors:  J Longmore; J J Maguire; A MacLeod; L Street; W N Schofield; R G Hill
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

Review 5.  Tolerability of the triptans: clinical implications.

Authors:  Giuseppe Nappi; Giorgio Sandrini; Grazia Sances
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 6.  Sumatriptan. An updated review of its use in migraine.

Authors:  C M Perry; A Markham
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

7.  5-HT1B-receptors and vascular reactivity in human isolated blood vessels: assessment of the potential craniovascular selectivity of sumatriptan.

Authors:  Z Razzaque; J D Pickard; Q-P Ma; D Shaw; K Morrison; T Wang; J Longmore
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

Review 8.  Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential.

Authors:  Andrea Negro; Angela Koverech; Paolo Martelletti
Journal:  J Pain Res       Date:  2018-03-08       Impact factor: 3.133

9.  Triptans and troponin: a case report.

Authors:  Claudia R Weder; Markus Schneemann
Journal:  Orphanet J Rare Dis       Date:  2009-06-18       Impact factor: 4.123

10.  Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors.

Authors:  J Longmore; Z Razzaque; D Shaw; A P Davenport; J Maguire; J D Pickard; W N Schofield; R G Hill
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.